Dialysis membrane: From convection to adsorption

NDT Plus

Volumn 3, Issue SUPPL. 1, 2010, Pages

  Santoro, Antonio ^a   Guadagni, Gualtiero ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

adsorption; convection; dialysis membranes; diffusion

Indexed keywords

CELLULOSE; POLY(METHYL METHACRYLATE); POLYMER; TOXIN;

ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIALYSATE; DIALYSIS; HUMAN; IMMUNOREGULATION; INFLAMMATION; PRIORITY JOURNAL; REVIEW;

EID: 77956050253     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfq035     Document Type: Review

References (31)

1. Bourè T, Vanholder R. Biochemical and clinical evidence for uremic toxicity. Artif Organs 2004; 28: 248-253
2. Cheung AK, Greene T, Leypoldt JK et al. Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 69-77
3. Eknoyan G, Beck GJ, Cheung AK et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Eng J Med 2002; 347: 2010-2019
4. Wizeman V, Lotz C, Techert F et al. Online haemodiafiltration versus low-flux hemodialysis. A prospective randomized study. Nephrol Dial transplant 2000; 15: S143-S148
5. Cheung AK, Rocco MV, Yan G et al. Serum beta-2-microglobulin levels predict mortality in dialysis patients. Results of the HEMO study. J Am Soc Nephrol 2006; 17: 546-555
6. Santoro A, Mancini E, Bolzani R et al. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. Am J Kidney Dis 2008; 52: 507-518
7. Woods HF, Nandakumar M. Improved outcome for hemodialysis patients treated with high-membranes. Nephrol Dial transplant 2000; 15: 36-42
8. Canaud B, Bragg-Gresham JL, Marshall MR et al. Mortality risk for patients receiving hemodiafiltration versus hemodialysis: European results from DOPPS. Kidney Int 2006; 69: 2087-2093
9. Ronco C, Levin N, Brendolan A et al. Flow distribution analysis by helical scanning in polysulfone hemodialyzers: effect of fibre structure and design on the flow patterns and solute clearances. Hemodial Int 2006; 10: 380-388
10. Ronco C. Evolution of Hemodiafiltration. In: C Ronco, B Canaud, P Aljama (eds). Hemodiafiltration. Contrib Nephrol. Basel: Karger, 2007; 158: 9-19
11. Locatelli F, Di Filippo S, Manzoni C. Removal of small and middle molecules by convective techniques. Nephrol Dial transplant 2000; 15: 37-44
12. Degiannis D, Czarnecki M, Donati D et al. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes. Am J Nephrol 1990; 10: 276-282
13. Maduell F, del Pozzo C, Garcia H et al. Change from conventional hemodiafiltration to on-line hemodiafiltration. Nephrol Dial Transplant 1999; 14: 1202-1207
14. Hoenich NA. Membranes and Filters for Haemodiafiltration. In: C Ronco, B Canaud, P Aljama (eds). Hemodiafiltration. Contrib Nephrol. Basel: Karger, 2007; 158: 57-77
15. Vanholder RC, Glorieux GL, De Smet RV. Back to the future: middle molecules, high flux membranes, and optimal dialysis. Medial Int 2003; 7: 52-57
16. Locatelli F, Martin-Malo A, Hannedouche T et al. Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol 2009; 20: 645-654
17. Santoro A, Panzetta O, Tessitore N et al. A European multicenter RCT on cardiovascular effects of acetate-free biofiltration (AFB) and conventional bicarbonate dialysis (BD) in chronic dialysis (CD) patients. J Am Soc Nephrol 2007; 18: 78A
18. Biasioli S et al. Role of cellulosic and noncellulosic membranes in hyperhomocysteinemia and oxidative stress. ASAIO Journal 2000; 46: 625-634
19. Tessitore T et al. Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels. J Nephrol 2004; 17: 707-714
20. Yamada S et al. Isolation of mast cell degranulation factor from dialysis patients with pruritus and its removal by dialysis membrane. Kidney Dialysis 2003; 55: 167-171
21. Contin C et al. Membrane-anchored CD40 is processed by the tumor necrosis factor-a-converting enzyme. J Biol Chem 2003; 278: 32801-32809
22. Campistol JM, Torregrosa JV et al. Beta2 microglobulin removal by hemodialysis with polymetilmetacrylate membranes. Contrib Nephrol 125: 85
23. Kawanishi H. Intensive & Critical Care Medicine 2000; 12: s7-s8. Proceedings
24. Lonnemann G. Chronic inflammation in hemodialysis: the role of contaminated dialysate. Blood Purifi 2000; 18: 214-223
25. Aoike I. Clinical significance of protein adsorbable membranes- long-term clinical effects and analysis using a proteomic technique. Nephrol Dial Transplant 2007; 22: v13-v19
26. Clark WR, Gao D. Low-molecular weight proteins in end-stage renal disease potential toxicity and dialysis removal mechanism. J Am Soc Nephrol 2002; 13: S41-S47
27. Lee WCR, Uchino S, Fealy N et al. Super high-flux hemodialysis at high dialysate flows: an ex vivo assessment. J Artif Organs 2004; 27: 24-28
28. Bellomo M, Haase M, Baldwin I et al. Hemodialysis membrane with a high-molecular-weight cutoff and cytokine levels in sepsis complicated by acute renal failure: a phase 1 randomized trial. Am J Kidney Dis 2007; 50: 296-304
29. Hutchison CA, Cockwell P, Reid S et al. Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Neprol 2007; 18: 886-895
30. Tellingen AV, Grooteman MPC, Bartels PCM et al. Long-term reduction in plasma homocysteine levels by super-flux dialyzers in hemodialysis patients. Kidney Int 2001; 59: 342-346
31. De Smet R, Dhondt A, Ellot E et al. Effect of super-flux cellulose triacetate dialyzer membrane on the removal of non-protein-bound and protein-bound uraemic solutes. Nephrol Dial transplant 2007; 22: 2006-2012